Cargando…

Drug Discovery Strategies for SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is a novel disease caused by the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of 2019 in Wuhan, China, and has rapidly spread worldwide. The search for a suitable vaccine as well as effective therapeutics for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shyr, Zeenat A., Gorshkov, Kirill, Chen, Catherine Z., Zheng, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2020
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569306/ https://www.ncbi.nlm.nih.gov/pubmed/32723801 http://dx.doi.org/10.1124/jpet.120.000123

Ejemplares similares

Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
por: Zhu, Wei, et al.
Publicado: (2021)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2
por: Zhang, Xiang-Ning, et al.
Publicado: (2021)

Updated Approaches against SARS-CoV-2
por: Li, Haiou, et al.
Publicado: (2020)

SARS-CoV-2, surgeons and surgical masks
por: Khalil, Mohammad Ibrahim, et al.
Publicado: (2021)

Impact of SARS-CoV-2 on neuropsychiatric disorders
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2021)

Experimental Models for SARS-CoV-2 Infection
por: Kim, Taewoo, et al.
Publicado: (2021)

Reinfection, recontamination and revaccination for SARS-CoV-2
por: Kullmann, Tamás, et al.
Publicado: (2022)

Effect of SARS-CoV-2 infection on the liver
por: Sanyaolu, Adekunle, et al.
Publicado: (2023)

Autoimmune liver diseases and SARS-CoV-2
por: Sgamato, Costantino, et al.
Publicado: (2023)

Interaction between hepatitis B virus and SARS-CoV-2 infections
por: Xiang, Tian-Dan, et al.
Publicado: (2021)

Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
por: van de Leemput, Joyce, et al.
Publicado: (2021)

Optical Biosensors for Virus Detection: Prospects for SARS‐CoV‐2/COVID‐19
por: Maddali, Hemanth, et al.
Publicado: (2020)

Dynamics of host immune responses to SARS-CoV-2
por: Taherkhani, Reza, et al.
Publicado: (2021)

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
por: Babiker, Ahmed, et al.
Publicado: (2021)

Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
por: Jung, Min Kyung, et al.
Publicado: (2021)

Bidirectional interplay between SARS-CoV-2 and autophagy
por: Zhou, Hao, et al.
Publicado: (2023)

When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2
por: Gao, Jie, et al.
Publicado: (2022)

Count on us: T cells in SARS-CoV-2 infection and vaccination
por: Kedzierska, Katherine, et al.
Publicado: (2022)

Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2
por: Simsek, Cem, et al.
Publicado: (2021)

The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico
por: García-López, Rodrigo, et al.
Publicado: (2022)

Molecular mechanisms implicated in SARS-CoV-2 liver tropism
por: Quarleri, Jorge, et al.
Publicado: (2022)

Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis
por: Zippi, Maddalena, et al.
Publicado: (2020)

The rapid adaptation of SARS-CoV-2–rise of the variants: transmission and resistance
por: Soh, Sandrine M., et al.
Publicado: (2021)

Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection
por: Canavero, Isabella, et al.
Publicado: (2021)

Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein
por: Wolf, Kyle A., et al.
Publicado: (2022)

Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective
por: Li, Dandan, et al.
Publicado: (2021)

Different kinds of stem cells in the development of SARS-CoV-2 treatments
por: Mata-Miranda, Monica Maribel, et al.
Publicado: (2021)

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
por: McLean, Gary, et al.
Publicado: (2022)

Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications
por: Al-Beltagi, Mohammed, et al.
Publicado: (2021)

Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
por: Lee, Eunjin, et al.
Publicado: (2021)

Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions
por: Shah, Masaud, et al.
Publicado: (2021)

Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives
por: Huang, Yi-Ke, et al.
Publicado: (2021)

COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review
por: Bonuomo, Valentina, et al.
Publicado: (2021)

Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus
por: Iwanicka, Joanna, et al.
Publicado: (2022)

Antiviral activity of medicinal plant-derived products against SARS-CoV-2
por: de Oliveira, Jonatas Rafael, et al.
Publicado: (2022)

Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Defensive Properties of Mucin Glycoproteins during Respiratory Infections—Relevance for SARS-CoV-2
por: Chatterjee, Maitrayee, et al.
Publicado: (2020)

Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
por: Simoneau, Camille R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6qr4dmpii5n4mqtv0mtqto46cg